JP Vert

@jpvert.bsky.social

AI and Biology. Want to cure cancer.

We’re excited to announce the first patient has been dosed in our Phase 1 clinical trial of OKN4395, a first-in-class EP2/EP4/DP1 triple inhibitor for solid tumors⁠. Learn more in STAT’s latest interview with Andrew Pierce, Owkin’s SVP Discovery & Development: www.statnews.com/2025/01/30/o...

How AI helps drug developers skirt pharma’s ‘dirty little secret’

Andrew Pierce, senior executive at French biotech Owkin, on how artificial intelligence can make the drug development process more efficient.

statnews.com

Honored to join @AcadTechnolog (National Academy of Technologies of France)! Grateful to my teachers, students, and collaborators over the years. I’ll strive to advance thoughtful, inclusive progress in tech and help society understand innovations like AI.

18 nouveaux membres élus à l’Académie des technologies - Académie des technologies

Communiqué de presse – Paris, le 16 décembre 2024 L’Académie des technologies renforce son expertise en accueillant 18 nouveaux membres choisis pour l’excellence de leur parcours et leur engagement…

buff.ly

I'm heading to #NeurIPS24 in Vancouver next week. Ping me if you'd like to meet up for a ☕ (preferably a ristretto for me...) and discuss how AI is transforming biology, or delve into more hardcore ML topics!